Pfizer's COVID-19 outlook cuts hit other vaccine maker shares
Pfizer set off a fresh round of concern about the size of the US COVID-19 vaccine and treatment market in the long term, driving down shares on Monday (Oct 16) of its German partner BioNTech and smaller rival Moderna. Vaccine makers are depending on the US market as many countries have more limited yearly